Northwestern Medicine | Northwestern University | Faculty Profiles
News Center
In a retrospective study, scientists developed and validated a gene expression signature that can predict which patients with prostate cancer will benefit most from postoperative radiotherapy.
Northwestern Medicine scientists have identified a protein that acts as a marker for a population of cells that may be an origin for prostate cancers.